
Olfactory dysfunction following COVID‐19 persisted in 29% of the patients after 1 year of infection. Phantosmia at baseline and 1 month were associated with a worse evolution, but their presence may represent ongoing regeneration. Longer follow‐up is required in these patients. SARS‐CoV‐2 (2019–2020 variants) produced a highly frequent OD that persisted in 29% of the patients after 1 year. The presence of phantosmia at baseline and 1 month was associated with a worse evolution, but phantosmia may interfere with the performance in an identification smell test. A longer follow‐up is required in these patients.
Like
Save
Share